Insider Stock Trading History of Koppel Adam


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Koppel Adam since year 2005. The trader's CIK number is 1578965. At the time of this reporting, Koppel Adam is the Director of Replimune Group, Inc. . (stock ticker symbol REPL). See this page for all insider trading activities at Replimune Group, Inc. .

Note that in the past Koppel Adam also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Koppel Adam since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-07-24 REPL Replimune Group, Inc. Buy 500,000 15.00 7,500,000
2018-06-25 APTX Aptinyx Inc. Buy 400,000 16.00 6,400,000
2018-01-30 SLDB Solid Biosciences Inc. Buy 300,000 16.00 4,800,000
2018-01-25 SLDB Solid Biosciences Inc. Option Ex 1,689,444 .00 0
2017-12-15 MRNS Marinus Pharmaceuticals Inc Sale 822,547 8.33 6,849,348
2017-12-18 MRNS Marinus Pharmaceuticals Inc Sale 300,000 7.50 2,251,500
2017-12-19 MRNS Marinus Pharmaceuticals Inc Sale 150,000 7.36 1,104,450
2017-12-18 DRNA Dicerna Pharmaceuticals Inc Buy 285,000 7.00 1,995,000
2017-12-18 DRNA Dicerna Pharmaceuticals Inc Option Ex 8,454,388 .00 0
2016-06-06 BIIB Biogen Inc. Sale 555 290.00 160,950
2016-06-02 BIIB Biogen Inc. Option Ex 1,643 .00 0
2016-04-06 BIIB Biogen Inc. Sale 102 275.00 28,050
2015-06-02 BIIB Biogen Inc. Option Ex 2,384 .00 0
2013-06-25 PTCT Ptc Therapeutics, Inc. Buy 1,250,000 15.00 18,750,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Koppel Adam (Director of Replimune Group, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.